The insulin-like growth factor I system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome

J Ren, P Anversa - Biochemical pharmacology, 2015 - Elsevier
Metabolic syndrome is a cluster of risk factors including obesity, dyslipidemia, hypertension,
and insulin resistance. A number of theories have been speculated for the pathogenesis of …

The insulin-like growth factor I system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome

J Ren, P Anversa - Biochemical pharmacology, 2015 - pubmed.ncbi.nlm.nih.gov
Metabolic syndrome is a cluster of risk factors including obesity, dyslipidemia, hypertension,
and insulin resistance. A number of theories have been speculated for the pathogenesis of …

The insulin-like growth factor I system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome.

J Ren, P Anversa - Biochemical Pharmacology, 2014 - europepmc.org
Metabolic syndrome is a cluster of risk factors including obesity, dyslipidemia, hypertension,
and insulin resistance. A number of theories have been speculated for the pathogenesis of …

[引用][C] The insulin-like growth factor I system: Physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome

J Ren, P Anversa - Biochemical Pharmacology, 2015 - cir.nii.ac.jp
The insulin-like growth factor I system: Physiological and pathophysiological implication in
cardiovascular diseases associated with metabolic syndrome | CiNii Research CiNii 国立情報学 …

The insulin-like growth factor I system: Physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome

J Ren, P Anversa - Biochemical Pharmacology, 2015 - infona.pl
Metabolic syndrome is a cluster of risk factors including obesity, dyslipidemia, hypertension,
and insulin resistance. A number of theories have been speculated for the pathogenesis of …